Maternal and Infant Syphilis Prevention Act
- Bill Number
- H.R. 3866
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-06-10: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-12-13T09:06:58Z
AI-Generated Summary
Purpose of the Legislation
The Maternal and Infant Syphilis Prevention Act (H.R. 3866) aims to address the rising rates of syphilis, particularly congenital syphilis (syphilis passed from mother to baby during pregnancy), by requiring the Secretary of Health and Human Services (HHS) to provide guidance on best practices for screening and treatment. This focuses on programs like Medicaid (a federal-state health insurance program for low-income individuals) and the Children's Health Insurance Program (CHIP, which provides health coverage to children in families with incomes too high for Medicaid but too low for private insurance). The goal is to improve early detection and prevention to reduce health risks like stillbirths, infant deaths, and long-term complications.
Key Provisions
- Findings Section: Outlines the public health crisis, including:
- Over 209,000 syphilis cases in 2023, an 80% increase since 2018—the highest since 1950.
- More than 3,800 congenital syphilis cases in 2023, up 3% from 2022, leading to 252 stillbirths and 27 infant deaths (over 10 times the 2012 rate).
- Risks of untreated syphilis, such as heart/brain damage, blindness, deafness, paralysis, miscarriage, and developmental issues in babies.
- Emphasis on timely testing during pregnancy preventing up to 90% of cases, but state screening requirements vary (most mandate first visit only; fewer require third trimester or delivery checks).
- Need for better education and awareness.
- Guidance and Technical Assistance (Section 3):
- Within 12 months of enactment, HHS must issue guidance to state Medicaid and CHIP agencies, the Indian Health Service (IHS, federal health services for Native Americans), Indian Tribes, tribal organizations, and urban Indian organizations.
- Guidance covers best practices for:
- Expanding access to syphilis screening for pregnant women and newborns.
- Educating healthcare providers and pregnant women about syphilis.
- Using telehealth (remote healthcare via technology) for services, including interpreter support and multilingual resources on congenital syphilis.
- Increasing testing in the third trimester of pregnancy and at delivery.
- Enhancing treatment for syphilis in mothers and babies.
- States and programs can use existing tools like waivers (temporary exceptions to program rules under Section 1115 of the Social Security Act) to implement these practices.
- Definitions: Clarifies terms like "State Medicaid program" and "State CHIP" (including their waivers), "Secretary" (HHS head), and terms related to Indian health programs (e.g., services for Native American communities under federal law).
- Reporting Requirement: Within 2 years of enactment, HHS must submit a public report to key congressional committees (House Energy and Commerce, Senate Health, Education, Labor and Pensions, and Senate Finance) analyzing how the best practices are being implemented.
Significant Changes to Existing Law
This bill introduces new federal requirements for HHS to develop and distribute specific guidance on syphilis prevention, which did not previously exist in federal law. It does not amend Medicaid or CHIP statutes directly but builds on them by encouraging the use of existing waiver authorities (under the Social Security Act) to adopt best practices. State screening rules remain variable, but the guidance promotes standardization without mandating changes.
Potential Impacts
- Government Agencies: HHS gains a mandate to produce guidance and a report, potentially increasing administrative workload but leveraging existing programs. State agencies, IHS, and tribal health entities may need to adjust operations to incorporate recommendations, possibly through waivers, leading to better coordination on public health.
- Citizens: Pregnant women and infants in Medicaid/CHIP (especially low-income families) could benefit from earlier screening and treatment, reducing congenital syphilis cases by up to 90% where implemented. This may prevent severe health issues, deaths, and long-term costs. Rural or underserved communities, including Native Americans, could see improved access via telehealth and education.
- International Relations: No direct impact, as the bill focuses on domestic U.S. health programs.
Main Stakeholders Affected
- Pregnant Women and Infants: Primary beneficiaries, particularly those in low-income or underserved groups covered by Medicaid/CHIP.
- Healthcare Providers: Doctors, nurses, and clinics involved in prenatal care, who will receive education and telehealth training.
- State and Federal Agencies: Medicaid/CHIP administrators, HHS, and IHS, responsible for implementing guidance.
- Native American Communities: Indian Tribes, tribal organizations, and urban Indian groups, explicitly included for tailored health services.
- Families and Communities: Broader impact on reducing syphilis transmission through awareness and multilingual resources.
Notable Legal, Constitutional, or Political Implications
- Legal: Relies on existing federal authorities (e.g., Social Security Act waivers) without creating new mandates, minimizing legal challenges. Guidance is advisory, giving states flexibility, which aligns with federalism (shared state-federal responsibilities in health programs).
- Constitutional: No apparent issues; it promotes public health under Congress's spending power for programs like Medicaid, without infringing on individual rights.
- Political: Bipartisan introduction (by Rep. Ciscomani, R-AZ, and Rep. Stansbury, D-NM) signals broad support for maternal/infant health. Could influence future public health funding or syphilis-specific initiatives, highlighting disparities in state screening laws. Referred to committees on Energy and Commerce and Natural Resources, indicating focus on health and tribal affairs.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (4)
Rep. Stansbury, Melanie A. [D-NM-1], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Escobar, Veronica [D-TX-16], Rep. Neguse, Joe [D-CO-2]
Recent Actions
- 2025-06-10: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-06-10: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-06-10: Introduced in House
- 2025-06-10: Introduced in House
Bill Versions
- Maternal and Infant Syphilis Prevention Act — issued 2025-06-10 — PDF (6 pages)